Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic
Haiden A. Huskamp, Alisa B. Busch, Lori Uscher‐Pines, Michael L. Barnett, Lauren Riedel, Ateev Mehrotra
Abstract
This study uses commercial and Medicare Advantage claims data to compare medication fills, outpatient visits, and urine tests for opioid use disorder in January-May 2020 vs 2019.
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)Context (archaeology)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Opioid use disorderPsychiatryOpioidPsychoanalysisFamily medicineVirologyInternal medicineDiseaseReceptorPsychologyPaleontologyBiologyOutbreakInfectious disease (medical specialty)Opioid Use Disorder TreatmentCOVID-19 and Mental Health